| Ana Medea Damme, | |
|
2115 14th St Ste 100, Auburn, NE 68305-1760 | |
| (402) 274-4993 | |
| Not Available |
| Full Name | Ana Medea Damme |
|---|---|
| Gender | Female |
| Speciality | Psychologist - Clinical Child & Adolescent |
| Location | 2115 14th St Ste 100, Auburn, Nebraska |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1225498207 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 101YM0800X | Counselor - Mental Health | 10243 (Nebraska) | Secondary |
| 103TC2200X | Psychologist - Clinical Child & Adolescent | 1034 (Nebraska) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Ana Medea Damme, Po Box 184, Talmage, NE 68448-0184 Ph: (402) 274-8853 | Ana Medea Damme, 2115 14th St Ste 100, Auburn, NE 68305-1760 Ph: (402) 274-4993 |
News Archive
Researchers have identified an approach to remove race from equations used to estimate a person's kidney function. These equations have been criticized for potentially perpetuating racial health disparities. The findings, reported September 23 in the New England Journal of Medicine, are expected to inform National Kidney Foundation–American Society of Nephrology Task Force guidelines on evaluating kidney function.
The Diabetes 2025 Model for the U.S. projects a continuous and dramatic increase in the diabetes epidemic and makes it possible to estimate the potential effects of society-wide changes in lifestyle and healthcare delivery systems.
Muscle deterioration in patients with lung diseases might be a direct consequence of high carbon dioxide levels in their blood, an international team of researchers headed by Prof. Yosef Gruenbaum of the Hebrew University of Jerusalem has found.
Given the amount of angst over male pattern balding, surprisingly little is known about its cause at the cellular level. In a new study, published in the Journal of Clinical Investigation, a team led by George Cotsarelis, MD, chair of the Department of Dermatology at the University of Pennsylvania School of Medicine, has found that stem cells play an unexpected role in explaining what happens in bald scalp.
Genta Incorporated announced that two new studies have shown that Genasense (oblimersen sodium) Injection, the Company's lead anticancer drug, showed synergistic activity with both bortezomib (Velcade; Millennium Pharmaceuticals, Inc.) and rituximab (Rituxan; Genentech, Idec) in experimental models of B-cell non-Hodgkin's lymphoma (NHL).
› Verified 7 days ago